Organon & Co.: Coronary Disease trials

The registry lists 12 Coronary Disease studies with Organon & Co. as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 3 7Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)CompletedNCT00730132Results posted
• The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)CompletedNCT00423579Phase 4Results posted
• Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)CompletedNCT00423488Phase 3Results posted
• Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)CompletedNCT00723723
• Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)CompletedNCT00651274Phase 4
• A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)CompletedNCT00551447Phase 3
• Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)CompletedNCT00202904Phase 4
• An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)CompletedNCT00092638Phase 3
• Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)CompletedNCT00092625Phase 3
• Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)CompletedNCT00092612Phase 3
• Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)CompletedNCT00092599Phase 3
• Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)CompletedNCT00090168Phase 3